Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Avricore Health (AVCRF) Debt to Equity (2020 - 2023)

Avricore Health has reported Debt to Equity over the past 4 years, most recently at $0.02 for Q4 2023.

  • Quarterly Debt to Equity fell 51.12% to $0.02 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $0.02 through Dec 2023, down 51.12% year-over-year, with the annual reading at $0.02 for FY2023, 51.12% down from the prior year.
  • Debt to Equity was $0.02 for Q4 2023 at Avricore Health, down from $0.02 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.04 in Q4 2022 and troughed at -$1.38 in Q4 2020.
  • The 4-year median for Debt to Equity is $0.02 (2021), against an average of -$0.15.
  • Year-over-year, Debt to Equity surged 123.71% in 2022 and then plummeted 51.12% in 2023.
  • A 4-year view of Debt to Equity shows it stood at -$1.38 in 2020, then skyrocketed by 101.32% to $0.02 in 2021, then surged by 123.71% to $0.04 in 2022, then plummeted by 51.12% to $0.02 in 2023.
  • Per Business Quant, the three most recent readings for AVCRF's Debt to Equity are $0.02 (Q4 2023), $0.02 (Q3 2023), and $0.04 (Q4 2022).